| Overview |
| bs-19161R-PE |
| ZGPAT Polyclonal Antibody, PE Conjugated |
| WB |
| Human, Mouse |
| Rat, Rabbit |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ZGPAT |
| 431-531/531 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 84619 |
| Q8N5A5 |
| Nucleus |
| dJ583P15.3; FLJ14972; G patch domain-containing protein 6; GPATC6; GPATCH6; KIAA1847; MGC44880; RP4 583P15.3; ZC3H9; ZC3HDC9; ZGPAT; ZGPAT_HUMAN; Zinc finger and G patch domain-containing protein; Zinc finger CCCH domain-containing protein 9; Zinc finger CCCH type with G patch domain1; Zinc finger CCCH-type with G patch domain-containing protein; ZIP. |
| ZGPAT is a 531 amino acid protein that contains a G-patch domain, which is typically found within RNA-binding proteins. Proteins that contain the G-patch domain include some tumor suppressor and DNA-damage repair proteins. ZGPAT also contains one C3H1-type zinc finger, which further supports its probable role as an RNA-binding protein. The gene encoding ZGPAT is inactivated via differential methylation in a oligodendroglioma cell line, suggesting that ZGPAT may have utility as a biomarker. There are two isoforms of ZGPAT that are produced as a result of alternative splicing events. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz